{"disease":{"id":"high-altitude-pulmonary-hypertension","name":"high altitude pulmonary hypertension"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03165656","title":"Right Ventricular Function at Rest in Highlanders/Lowlanders","phase":"","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT03165032","title":"Right Ventricular Function During Exercise in Highlanders/Lowlanders","phase":"","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT03165019","title":"Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.","phase":"","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06489730","title":"HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06852924","title":"Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Novlead Inc.","has_results":false},{"nct_id":"NCT03172429","title":"Cerebral Tissue Oxygenation in Highlanders/Lowlanders","phase":"","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06489756","title":"Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05107700","title":"Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500m","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05264324","title":"Maximal Exercise Capacity at 2500 m of High Altitude","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05089487","title":"Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05131737","title":"Exercise Endurance Time on the 2nd Day at 2500 m High Altitude","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06489704","title":"High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06489743","title":"Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06489691","title":"High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m)","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06489717","title":"High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m)","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05112172","title":"Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"University of Zurich","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}